FindTrial
Sign In

Use of blood test to see the parameter which helps in evaluation of patients with bacterial infection

Use of PROCALCITONIN in determining different microbes and outcome in an Intensive Care Unit (ICU)- A retrospective observational study - procal

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/05/019190
Enrollment
300
Registered
2019-05-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A499- Bacterial infection, unspecified

Interventions

None listed

Sponsors

Dr SK Jagadish Chandran
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All ICU patients on whom procalcitonin was done from 01/01/2018 to 31/12/2018

Exclusion criteria

Exclusion criteria: NIL

Design outcomes

Primary

MeasureTime frame
To assess the correlation of PCT level with different microbes Timepoint: ICU Mortality—

Secondary

MeasureTime frame
To assess patientâ??s clinical profile and outcome with PCT levelsTimepoint: Hospital Mortality—

Countries

India

Contacts

Public ContactDr Amarja Ashok Havaldar

St Johns medical college

amarjahavaldar@rediffmail.com9036082112

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026